Randomized, Double‐Blind, Controlled Study of Cefoperazone‐Sulbactam Plus Cotrimoxazole versus Ceftazidime Plus Cotrimoxazole for the Treatment of Severe Melioidosis
Open Access
- 1 July 2001
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (1) , 29-34
- https://doi.org/10.1086/320878
Abstract
We conducted a prospective randomized, double-blind, controlled study of cefoperazone-sulbactam (ratio, 1 : 1; cefoperazone 25 mg/kg/day) plus cotrimKeywords
This publication has 12 references indexed in Scilit:
- Comparison of Imipenem and Ceftazidime as Therapy for Severe MelioidosisClinical Infectious Diseases, 1999
- Ceftazidime vs. Amoxicillin/Clavulanate in the Treatment of Severe MelioidosisClinical Infectious Diseases, 1994
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992
- Multicenter prospective randomized trial comparing ceftazidime plus co-trimoxazole with chloramphenicol plus doxycycline and co-trimoxazole for treatment of severe melioidosisAntimicrobial Agents and Chemotherapy, 1992
- Pseudomonas pseudomallei, a common pathogen in Thailand that is resistant to the bactericidal effects of many antibioticsAntimicrobial Agents and Chemotherapy, 1991
- Melioidosis: the tip of the iceberg?Clinical Microbiology Reviews, 1991
- HALVING OF MORTALITY OF SEVERE MELIOIDOSIS BY CEFTAZIDIMEThe Lancet, 1989
- Melioidosis: Review and UpdateClinical Infectious Diseases, 1989
- Antimicobial susceptibility of Psedomonas pseudomalleiJournal of Antimicrobial Chemotherapy, 1987
- In Vitro Susceptibility of Strains of Pseudomonas pseudomallei Isolated in Thailand and Hong Kong to Some Newer -Lactam Antibiotics and Quinolone DerivativesThe Journal of Infectious Diseases, 1986